|
Novo Nordisk A/S
(NVO)
|
| |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Other |
| Top Industry Grower: | N/A |
NVO was last updated 39 days 23 hours 35 minutes ago. Use MrStockQuickie's
Free Value Investor Tool to view this data in real time.
The Numbers
| metric | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
| Return on Capital | 13.3% | 13.2% | 17.9% | 20.8% | 18.3% | 19.6% | 18.6% | 20.6% | 21.5% | 26.6% | 29.5% |
| Equity/Share | $3.81 | $3.51 | $2.81 | $3.46 | $4.64 | $6.22 | $7.16 | $6.65 | $8.26 | $9.92 | $10.45 |
| Earnings/Share | $0.49 | $0.49 | $0.56 | $0.66 | $0.74 | $1.08 | $1.24 | $1.50 | $1.68 | $2.46 | $2.86 |
| FCF/Share | $0.27 | $0.34 | $0.51 | $0.01 | $0.15 | $0.81 | $1.10 | $1.23 | $1.26 | $2.22 | $2.66 |
| Sales/Share | $3.61 | $4.24 | $3.69 | $4.09 | $4.56 | $5.88 | $7.20 | $8.63 | $10.08 | $12.08 | $13.54 |
| Gross Margin | 75.5% | 75.9% | 79.0% | 74.9% | 73.7% | 72.0% | 72.3% | 72.8% | 75.3% | 76.6% | 76.8% |
The Trends
long term trend
| ROIC | BVPS | EPS | FCFPS | SPS |
| 2% | 3% | 5% | 5% | 4% |
|
growth acceleration trend
| ROIC | BVPS | EPS | FCFPS | SPS |
| 3% | 0% | 2% | 3% | 0% |
|
Quick Financial Health
cash/debt
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
| 1.2 | 0.8 | 2.96 | 2.57 | 3.14 | 3.2 | 4.11 | 3.44 | 4.85 | 6.85 | 6.44 |
|
growth
| 10 | 5 | 3 | 1 |
| 18% | 15% | 23% | -6% |
|
equity/debt
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
| Low Debt | Low Debt | Low Debt | 25.0 | 25.0 | 33.33 | 25.0 | 20.0 | 25.0 | 33.33 | Low Debt |
|
growth
| 10 | 5 | 3 | 1 |
| 0% | 686% | 3,584% | 2,999,900% |
|
assets/liabilities
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
| 2.92 | 2.49 | 2.78 | 3.3 | 3.68 | 3.75 | 3.43 | 2.93 | 3.07 | 3.07 | 2.92 |
|
|
The Ratios
PEG
| Entity | Current | Next Year (Current PE) | Next Year (Forward PE) | Five Year |
| NVO | 3.51 | 4.97 | 4.13 | 1.04 | | Industry | 0.00 | 0.00 | 0.00 | 9.88 | | Market | 0.00 | 0.00 | 0.00 | 1.01 |
|
Valuations
| Entity | Price/Earnings | Price/Book | Price/Sales | Price/Cash Flow | Div. Yield (%) |
| NVO | 20.7 | 5.7 | 4.1 | 16.6 | 1.9 | | Industry | 15.5 | 2.8 | 2.4 | 9.1 | 0.9 | | Market | 12.7 | 2.9 | 1.7 | 8.9 | 3.6 |
|
The Pricing Metrics
Growth Rates
| Zacks | Reuters | Thomson Fin. | BVPS | EPS | FCFPS | SPS |
| 16.5% | 16.5% | 16.5% | 12.7% | 22.5% | 24.7% | 16.3% | | Next Year's Growth Estimate | 4.2% | | Priced-In Growth | 16.5% | | Intrinsic Growth | 17.8% |
|
Mulitple History
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
| 0.9 | 0.7 | 0.7 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 19.4 | | Front Loaded Estimate | 6.9 | | High Growth Estimate | 33.0 | | Five Year Avgerage | 21.1 |
|
Quality and Value
Quality (0-10)
| Inferior | Low | Below Avg. | Average | Above Avg. | High | Superior |
| | | | | | | 10.2 |
|
Valuations
| | PE | EPS | PRICE | VALUE/PRICE | MOS |
| Current Price | 20.7 | $2.30 | $47.67 | 1.000 | 0.0% | | Intrinsic Value | 6.9 | $2.43 | $16.74 | 0.351 | -184.8% | | Price Adjusted for Industry | 0.0 | $2.30 | $0.00 | 0.000 | -∞% | | Price Adjusted for Market | 0.0 | $2.30 | $0.00 | 0.000 | -∞% | | EPS estimated FY08 Price | 20.1 | $2.86 | $57.38 | 1.204 | 16.9% | | EPS Quality (OIPS/E) | 1.17 | | Cash Quality (FCFPS/EPS) | 1.09 |
|